pharma · Renal Transplantation · Rheumatoid Arthritis (RA)
Astellas Pharma
Astellas Pharma Inc
Astellas Pharma is a pharma organization headquartered in CN. Primary therapeutic focus areas include Renal Transplantation, Rheumatoid Arthritis (RA), Non-small Cell Lung Cancer, Restless Legs Syndrome, Hot Flashes. Nov
2-5-1, Nihonbashi-Honcho, Chuo-Ku, Tokyo 103-8411, JP HQ
12,378 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- 2-5-1, Nihonbashi-Honcho, Chuo-Ku, Tokyo 103-8411, JP
- Employees
- 12,378
- Programs
- 20
- Drugs
- 12
- Patents
- 25
Mirabegron
Phase 3 · small molecule · Overactive Bladder (OAB)
Mirabegron for Overactive Bladder (OAB) is a Phase 3 program (small_molecule) at Astellas Pharma Inc with 1 ClinicalTrials.gov record(s).
Internal code 178-CL-204
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Astellas Pharma Inc
- Phase
- Phase 3
- Modality
- small_molecule
- Indication
- Overactive Bladder (OAB)
- Status
- terminated
- Trials
- 1